Signs Of Life In The Bacterial Vaginosis, Vulvovaginal Candidiasis Pipeline

 
• By Bridget Silverman

Scynexis highlights enrollment exceeding expectations in Phase III VVC trials; Daré prepares to enter Phase III to treat BV.

More from Archive

More from Pink Sheet